Dr. Michael Chapman's lab at the University of Missouri-Columbia focuses on improving gene therapy using adeno-associated viruses (AAV). They study how AAV interacts with host cells to better understand its entry process and develop more efficient gene delivery methods. Their research aims to design safer and more effective AAV vectors that can potentially treat various genetic diseases.